3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
28
Gastrointestinal Stromal Tumors
4
Colonic Neoplasms
4
Carcinoma, Hepatocellular
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Neoplasms
3
Neoplasm Metastasis
3
Rectal Neoplasms
2
Gallbladder Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Bile Duct Neoplasms
2
Urothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer)
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Somatostatinoma
1
Sarcoma
1
Rhabdomyosarcoma
1
Renal Insufficiency
1
Physician Education
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Noonan Syndrome 6
1
Metastatic Pancreatic Adenocarcinoma
1
Melanoma
1
Liver Neoplasms
1
Liposarcoma
1
Insulinoma
1
Interventions
fludarabine phosphate
28
Peripheral Blood Stem Cell Transplantation
25
Cyclophosphamide
24
Whole-Body Irradiation
22
Busulfan
22
Tacrolimus
19
Mycophenolic Acid
19
Methotrexate
15
Antilymphocyte Serum
13
Cyclosporine
12
Melphalan
9
Filgrastim
9
Cytarabine
9
Etoposide
8
Cord Blood Stem Cell Transplantation
7
fludarabine
6
Thiotepa
6
Methylprednisolone
6
Imatinib Mesylate
5
Granulocyte Colony-Stimulating Factor
5
thymoglobulin
4
merphos
4
Sirolimus
4
Rituximab
4
Radiotherapy
4
Flow Cytometry
4
Dexamethasone
4
Dasatinib
4
Cyclosporins
4
Calcium Dobesilate
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Blast Crisis
×
regorafenib
×
Clear all
No trials found.